The 7th International Multidisciplinary Breast Conference, themed “Advancing De-escalation of Therapy and Addressing Controversies,” was held from February 8th to 10th, 2023, at the prestigious Hyatt Regency Hotel in Dubai, UAE. Distinguished experts in the field, including Dr. Mohamed Al-Bashir, Dr. Mahmoud El Tamer, and Dr. Hassan Jaafar, delivered keynote messages, enriching the conference with their insights.
Day 1 of the conference commenced with a duo of enlightening workshops. The inaugural session, an immersive oncoplastic hands-on workshop, was helmed by the distinguished duo of Dr. Mahmoud El-Tamer and Dr. Mohamed Al Bashir. Following this, a workshop on transformative leadership, led by the esteemed Dr. Rola Shaheen, empowered attendees with invaluable leadership insights.
Day 2 showcased further enriching workshops, featuring a hands-on breast radiology session spearheaded by Dr. Kinda Douaidari and Dr. Adnan Kassis. Concurrently, a workshop dedicated to HER2 low pathology and oncology, led by the erudite Dr. Hassan Jaafar and Dr. Asif Quadri, captivated participants. Additionally, a workshop on oncology nursing, steered by Mr. Khaled Al Qawasmeh and Mr. Mahmoud Hassan, underscored the vital role of nursing in comprehensive patient care. The day culminated with a dynamic hybrid conference, comprising diverse sessions expertly moderated by luminary figures in the field.
Day 3 dawned with sessions focused on Triple Negative and HER2+ Breast Cancer, expertly moderated by Dr. Serife Simsek and Dr. Aydah Alawadhi. Noteworthy discussions included an exploration of innovative care paradigms for HER2+ Breast Cancer Patients with Phesgo, led by the esteemed Dr. Dalia Elshourbagy. The day unfolded with illuminating sessions delving into Metastatic Breast Cancer, a compelling Tumor Board discussion, and an incisive examination of Controversies in Breast Cancer, guided by eminent professionals.
The conference provided an invaluable forum for dialogue, education, and collaboration among leaders and professionals in the field of breast cancer treatment and research. It facilitated the exchange of the latest advancements and insights, driving efforts towards improving patient care and outcomes.